Market Place
Sourcing Support
INOVIO Reports Q3 2024 Financial Results & Updates
14 Nov 2024 //
PR NEWSWIRE
INOVIO’s INO-3107 Expands T Cells, Reduces RRP Surgeries
13 Nov 2024 //
PR NEWSWIRE
INOVIO to Report Q3 2024 Financial Results on November 14, 2024
06 Nov 2024 //
PR NEWSWIRE
INOVIO to Present at Upcoming Scientific Conferences
06 Nov 2024 //
PR NEWSWIRE
INOVIO Announces New Data For INO-3107 At Scientific Conferences
21 Oct 2024 //
PR NEWSWIRE
INOVIO Reports Inducement Grants Under Inducement Plan
02 Oct 2024 //
PR NEWSWIRE
INOVIO to Present at Upcoming Scientific Conferences
01 Oct 2024 //
PR NEWSWIRE
INOVIO to Present at Upcoming Scientific Conference
17 Sep 2024 //
PR NEWSWIRE
INOVIO Reports Q2 2024 Results And Business Highlights
08 Aug 2024 //
PR NEWSWIRE
INOVIO Reports Inducement Grant Under Inducement Plan
01 Aug 2024 //
PR NEWSWIRE
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024
25 Jul 2024 //
PR NEWSWIRE
Inovio Receives EMA Certificate For INO-3107 Quality And Non-Clinical Data
25 Jul 2024 //
PR NEWSWIRE
INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
02 Jul 2024 //
PR NEWSWIRE
INOVIO Added to Russell 2000® Index Effective July 1, 2024
01 Jul 2024 //
PR NEWSWIRE
Inovio Reports Inducement Grant Under Inducement Plan
01 Jul 2024 //
PR NEWSWIRE
INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
04 Jun 2024 //
PR NEWSWIRE
INOVIO Reports Q1 2024 Results, Business Highlights
13 May 2024 //
PR NEWSWIRE
INOVIO to Participate in Upcoming Investor Conferences in May
29 Apr 2024 //
PR NEWSWIRE
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
29 Apr 2024 //
PR NEWSWIRE
INOVIO Prices $36M Common Stock, Pre-Funded Warrants Offering
15 Apr 2024 //
PR NEWSWIRE
Inovio Pharma stock underperforms Tuesday when compared to competitors
12 Mar 2024 //
MARKETWATCH
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
08 Mar 2024 //
MARKETWATCH
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
PR NEWSWIRE
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results
21 Feb 2024 //
PR NEWSWIRE
INOVIO to Present at the Oppenheimer 34th Annual Life Sciences Conference
07 Feb 2024 //
PR NEWSWIRE
INOVIO Reports Inducement Grant Under Inducement Plan
02 Feb 2024 //
PR NEWSWIRE
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
23 Jan 2024 //
PR NEWSWIRE
INOVIO to Participate in Virtual Fireside Chat
22 Jan 2024 //
PR NEWSWIRE
INOVIO and Coherus Announce Clinical Collaboration
04 Jan 2024 //
PR NEWSWIRE
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP
03 Jan 2024 //
PR NEWSWIRE
Inovio drafts accelerated approval talking points for FDA visit
10 Nov 2023 //
FIERCE BIOTECH
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
09 Nov 2023 //
PR NEWSWIRE
INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023
26 Oct 2023 //
PR NEWSWIRE
INOVIO Receives FDA Feedback that Data from Completed Ph 1/2 Trial of INO-3107
10 Oct 2023 //
PR NEWSWIRE
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107
07 Sep 2023 //
PR NEWSWIRE
Inovio spinout plans study for cancer vaccine as it touts take on PhIb/IIa data
22 Aug 2023 //
ENDPTS
Inovio says no-go on phase 3 program, lays off 30% of staff
10 Aug 2023 //
FIERCE BIOTECH
INOVIO Announces Second Quarter 2023 Financial Results
09 Aug 2023 //
PR NEWSWIRE
INOVIO Reports Inducement Grants Under Inducement Plan
04 Aug 2023 //
PR NEWSWIRE
Inovio prunes headcount again; Aulos adds to Series A
01 Aug 2023 //
ENDPTS
INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023
26 Jul 2023 //
PR NEWSWIRE
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder
23 Jun 2023 //
GLOBENEWSWIRE
INOVIO Reports Inducement Grants Under Inducement Plan
01 Jun 2023 //
PR NEWSWIRE
INOVIO to Present at the 2023 Jefferies Healthcare Conference
25 May 2023 //
PR NEWSWIRE
INOVIO Announces Orphan Drug Designation for INO-3107
23 May 2023 //
PR NEWSWIRE
INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights
10 May 2023 //
PR NEWSWIRE
New Data from Ph1/2 Trial of INO-3107 for the Treatment of ABEA during COSM 2023
08 May 2023 //
PR NEWSWIRE
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference
05 May 2023 //
PR NEWSWIRE
INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023
28 Apr 2023 //
PR NEWSWIRE
Study Demonstrates the Effectiveness of Rare Medical Network Content Marketing
27 Apr 2023 //
PR NEWSWIRE
European Committee Provides Positive Opinion on INOVIO`sINO-3107
26 Apr 2023 //
PR NEWSWIRE
INOVIO Announces Acceptance of Abstract for Presentation on INO-4201
12 Apr 2023 //
PR NEWSWIRE
INOVIO Reports Inducement Grant Under Inducement Plan
03 Apr 2023 //
PR NEWSWIRE
INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference
03 Mar 2023 //
PR NEWSWIRE
Inovio`s endpoint switcheroo backfires as phase 3 fails new test
02 Mar 2023 //
FIERCE BIOTECH
INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results
01 Mar 2023 //
PR NEWSWIRE
INOVIO Announces Positive Results from Phase 1/2 Trial with INO-3107
16 Feb 2023 //
PR NEWSWIRE
Inovio to Report Fourth Quarter and Year-End 2022 Financial Results on March 1
15 Feb 2023 //
PR NEWSWIRE
INOVIO Reports Inducement Grants Under Inducement Plan
03 Feb 2023 //
PR NEWSWIRE
Inovio hopes Ebola booster data can boost fortunes, too
02 Feb 2023 //
FIERCE BIOTECH
